Localization of a calcium-dependent epitope to the amino terminal region of the Gla domain of human factor IX

Thrombosis Research

Volumn 81, Issue 1, 1996, Pages 65-73

  Cheung, Wing Fai ^a,c   Stafford, Darrel W ^a   Sugo, Teruko ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Calcium dependent antibody; Epitope mapping; Factor IX

Indexed keywords

BLOOD CLOTTING FACTOR 9; CALCIUM; EPITOPE;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030047256     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00214-6     Document Type: Article

References (28)

1. DAVIE, E.W., FUJIKAWA, K. and KISIEL, W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30, 10363-10370, 1991.
2. 2+ on the kinetic parameters of the activation of factor IX by factor XIa. J. Biol. Chem. 257, 4127-4132, 1982.
3. NELSESTUEN, G.L. Role of γ-carboxyglutamic acid: An unusal protein transition required for the calcium-dependent binding of prothrombin to phospholipid. J. Biol. Chem. 251, 5648-5656, 1976.
4. JONES, M.E., GRIFFITH, M.J., MONROE, D.M., ROBERTS, H.R. and LENTZ, B.R. Comparison of lipid binding and kinetic properties of normal, variant, and γ-carboxyglutamic acid modified human factor IX and factor IXa. Biochemistry 24, 8064-8069, 1985.
5. BURRI, B.J., EDGINGTON, T.S. and FAIR, D.S. Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles. Biochim. Biophys. Acta 923, 176-186, 1987.
6. POLLOCK, J.S., SHEPARD, A.J., WEBER, D.J., OLSON, D.L., KLAPPER, D.G., PEDERSEN, L.G. and HISKEY, R.G. Phospholipid binding properties of bovine prothrombin peptide residues 1-45. J. Biol. Chem. 263, 14216-14223, 1988.
7. SCHWALBE, R.A., RYAN, J., STERN, D.M., KISIEL, W., DAHLBÄCK, B. and NELSESTUEN, G.L. Protein structural requirements and properties of membrane binding by γ-carboxyglutamic acid-containing plasma proteins and peptides. J. Biol. Chem. 264, 20288-20296, 1989.
8. RAWALA-SHEIKH, R., AHMAD, S.S., ASHBY, B. and WALSH, P.N. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 29, 2606-2611, 1990.
9. HEIMARK, R.L. and SCHWARTZ, S.M. Binding of coagulation factors IX and X to the endothelial cell surface. Biochem. Biophys. Res. Commun. 111, 723-731,1983.
10. STERN, D.M., DRILLINGS, M., NOSSEL, H.L., HURLET-JENSEN, A., LAGAMMA, K.S. and OWEN, J. Binding of factors IX and IXa to cultured vascular endothelial cells. Proc. Natl. Acad. Sci. USA 80, 4119-4123, 1983.
11. CHEUNG, W.-F., HAMAGUCHI, N., SMITH, K.J. and STAFFORD, D.W. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J. Biol. Chem. 267, 20529-20531, 1992.
12. DEERFIELD, D.W., OLSON, D.L., BERKOWITZ, P., BYRD, P.A., KOEHLER, K.A., PEDERSEN, L.G. and HISKEY, R.G. Mg(II) binding by bovine prothrombin fragment 1 via equilibrium dialysis and the relative roles of Mg(II) and Ca(II) in Blood coagulation. J. Biol. Chem. 262, 4017-4023.
13. 2+ ion and membrane binding structure of the GIa domain of Ca-prothrombin fragment 1. Biochemistry 31, 2554-2566, 1992.
14. BOROWSKI, M., FURIE, B.C., BAUMINGER, S. and FURIE, B. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. J. Biol. Chem. 261, 14969-14975, 1986.
15. LIEBMAN, H.A., FURIE, B.C. and FURIE, B. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa. J. Biol. Chem. 262, 7605-7612, 1987.
16. SUGO, T., MIZUGUCHI, J., KAMIKUBO, Y. and MATSUDA, M. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations. Thromb. Res. 58, 603-614, 1990.
17. CHEUNG, W.-F., WOLBERG, A.S., STAFFORD, D.W. and SMITH, K.J. Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX. Thromb. Res. (in press).
18. SMITH, K.J. and ONO, K. Monoclonal antibodies to factor IX: Characterization and use in immunoassays for factor IX. Thromb. Res. 33, 211-224, 1984.
19. SMITH, K.J., SINGARAJU, C. and SMITH, L.F. Factor IX metal ion-dependent antigen assays for measurement of warfarin effect. Am. J. Clin. Pathol. 87, 370-376, 1987.
20. FRAZIER, D., SMITH, K.J., CHEUNG, W.-F., WARE, J., LIN, S.-W., THOMPSON, A.R., REISNER, H., BAJAJ, P. and STAFFORD, D.W. Mapping of monoclonal antibodies to human factor IX. Blood 74, 971-977, 1989.
21. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C. and NAIRN, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72, 1977.
22. STANSSENS, P., OPSOMER, C., McKEOWN, Y.M., KRAMER, W., ZABEAU, M. and FRITZ, H.J. Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucl. Acids Res. 17, 4441-4454, 1989.
23. ANDERSSON, S., DAVIS, D.L., DAHLBÄCK, H., JÖRNVALL, H. and RUSSEL, D.W. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264, 8222-8229,1989.
24. MNagoya 2, Factor IX Nagoya 3 and 4). Thromb. Haemostas. 65, 514-520, 1991.
25. STERN, D., NAWROTH, P., HANDLEY, D. and KISIEL, W. An endothelial cell-dependent pathway of coagulation. Proc. Natl. Acad. Sci. USA 82, 2523-2527, 1985.
26. WELSCH, D.J. and NELSESTUEN, G.J. Amino-terminal alanine functions in a calcium-specific process essential for membrane binding by prothrombin fragment 1. Biochemistry 27, 4939-4945, 1988.
27. DIUGUID, D.L., RABIET, M.J., FURIE, B.C., LIEBMAN, H.A. and FURIE, B. Molecular basis of hemophilia B: A defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Proc. Natl. Acad. Sci. USA 83, 5803-5807, 1986.
28. BRISTOL, J.A., FREEDMAN, S.J., FURIE, B.C. and FURIE, B. Profactor IX: The propeptide inhibits binding to membrane surfaces and activation by factor XIa. Biochemistry 33, 14136-14143, 1994.